New Jersey Retina

Edison, New Jersey 08820

0 studies enrolling now · 1 studies all time

What they study most

Nonproliferative Diabetic Retinopathy

Studies at this site

• The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) — Completed